Cytophagic histiocytic panniculitis is a disorder manifested by multiple subcutaneous nodules, characterized by lobular panniculitis, and occasionally accompanied by severe systemic manifestations, which require an aggressive medical approach. Several case reports with a good response to immunosuppressive therapy in the acute phase can be found in the literature.
Objective and Conclusion:
Nevertheless, the long-term evolution of this entity has not been described yet, nor have precise recommendations regarding the most adequate posology and duration of therapy. We report the result of switching from a long-term cyclosporine therapy to tacrolimus in a patient with a severe form of cytophagic histiocytic panniculitis.
Get full access to this article
View all access options for this article.
References
1.
WinkelmannRKBowieEJ. Hemorrhagic diathesis associated with benign histiocytic, cytophagic panniculitis and systemic histiocytosis. Arch Intern Med1980;140:1460–3.
2.
Al ZolibaniAAAl RobaeeAAQureshiMG. Subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome successfully treated with cyclosporin A. Skinmed2006;5:195–7.
3.
PhelpsRGShojiT. Update on panniculitis. Mt Sinai J Med2001;68:262–7.
4.
AlegreVAWinkelmannRK. Histiocytic cytophagic panniculitis. J Am Acad Dermatol1989;20:177–85.
5.
HytiroglouPPhelpsRGWattenbergDJ. Histiocytic cytophagic panniculitis: Molecular evidence for a clonal T-cell disorder. J Am Acad Dermatol1992;27:333–6.
6.
CrottyCPWinkelmannRK. Cytophagic histiocytic panniculitis with fever, cytopenia, liver failure, and terminal hemorrhagic diathesis. J Am Acad Dermatol1981;4:181–94.
7.
GonzalezCLMedeirosLJBrazielRM. T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol1991;15:17–27.
8.
AronsonIKWestDPVariakojisD. Panniculitis associated with cutaneous T-cell lymphoma and cytophagocytic histiocytosis. Br J Dermatol1985;112:87–96.
9.
PetersMSWinkelmannRK. Cytophagic panniculitis and B cell lymphoma. J Am Acad Dermatol1985;13:882–5.
10.
WhiteJWJrWinkelmannRK. Cytophagic histiocytic panniculitis is not always fatal. J Cutan Pathol1989;16:137–44.
11.
MalaviyaANHussainMAAbdeenS. Cytophagic histiocytic panniculitis: A rare catastrophic form of systemic panniculitis. Br J Rheumatol1998;37:799–800.
12.
SzyszymarBGwiezdzinskiZ. Treatment of recurrent panniculits febrillis nonsuppurativa with methotrexate. Przegl Dermatol1974;61:623–7.
13.
HottaTWakamatsuYMatsumuraN. Azathioprine-induced remission in Weber-Christian disease. South Med J1981;74:234–7.
14.
PetryRTrenknerGReichenbergerM. The treatment of recurring, febrile, nonsuppurative panniculitis (Pfeifer-Weber-Christian) using an immunosuppressive agent (azathioprine). Med Welt1968;48:2658–61.
15.
SorensenRUAbramowskyCSternRC. Corticosteroid-sparing effect of hydroxychloroquine in a patient with early-onset Weber-Christian syndrome. J Am Acad Dermatol1990;23:1172–4.
16.
BarthelHRCharrierUKramerM. Successful treatment of idiopathic febrile panniculitis (Weber-Christian disease) with thalidomide in a patient having failed multiple other medical therapies. J Clin Rheumatol2002;8:256–9.
17.
KirchWDuhrsenUHoenschH. Cyclophosphamide-induced remission in Weber-Christian panniculitis. Rheumatol Int1985;5:239–40.
18.
MatsueKItohMTsukudaK. Successful treatment of cytophagic histiocytic panniculitis with modified CHOP-E. Cyclophosphamide, Adriamycin, vincristine, predonisone, and etoposide. Am J Clin Oncol1994;17:470–4.
19.
UsukiKKitamuraKUrabeA. Successful treatment of Weber-Christian disease by cyclosporin A. Am J Med1988;85:276–8.
20.
PetterssonTKariniemiALTervonenS. Cytophagic histiocytic panniculitis: A report of four cases. Br J Dermatol1992;127:635–40.
21.
SteiningerHMissmahlM. Weber-Christian panniculitis with systemic cytophagic histiocytosis. Klin Wochenschr1988;66:365–72.
22.
RisdallRJMcKennaRWNesbitME. Virus-associated hemophagocytic syndrome: A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer1979;44:993–1002.
23.
ZuazuJPDuranJWJuliaAF. Hemophagocytosis in acute brucellos. N Engl J Med1979;301:1185–6.
ItoMOhiraHMiyataM. Cytophagic histiocytic panniculitis improved by combined CHOP and cyclosporin A treatment. Intern Med1999;38:296–301.
26.
EntzianPBarthJMonigH. Treatment of Weber-Christian panniculitis with cyclosporine A. Rheumatol Int1987;7:181.
27.
NakaneSKawabeYEguchiK. A case of cytophagic histiocytic panniculitis: Successful treatment of recurrent attacks with steroid pulse therapy and oral cyclosporin A. Clin Rheumatol1997;16:417–21.
28.
ViravanSWisuthsarewongWManonukulJ. Successful treatment of cytophagic histiocytic panniculitis by cyclosporin A: A case report. Asian Pac J Allergy Immunol1997;15:161–6.
29.
OstrovBEAthreyaBHEichenfieldAH. Successful treatment of severe cytophagic histiocytic panniculitis with cyclosporine A. Semin Arthritis Rheum1996;25:404–13.
30.
HinataMSomeyaTYoshizakiH. Successful treatment of steroid-resistant Weber-Christian disease with biliary ductopenia using cyclosporin A. Rheumatology (Oxford)2005;44:821–3.
31.
WiederrechtGLamEHungS. The mechanism of action of FK-506 and cyclosporin A. Ann N Y Acad Sci1993;696:9–19.
32.
KellyPABurckartGJVenkataramananR. Tacrolimus: A new immunosuppressive agent. Am J Health Syst Pharm1995;52:1521–35.
33.
IwasakiTHamanoTOgataA. Successful treatment of a patient with febrile, lobular panniculitis (Weber-Christian disease) with oral cyclosporin A: Implications for pathogenesis and therapy. Intern Med1999;38:612–4.
34.
JiSMLiLSShaGZ. Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy. Transplant Proc2007;39:1402–5.
35.
KasiskeBL. Cardiovascular disease after renal transplantation. Semin Nephrol2000;20:176–87.
